Question 20 | Physiological control of systemic vascular resistance (SVR). |
Question 5 | Beta-blockers - labetalol vs esmolol |
Question 17 | |
Question 13 | |
Question 11 | Amiodarone: side effects |
Question 9 | Classification of β-blockers; also metoprolol vs esmolol |
Question 3 |
Question 20 | |
Question 19 | |
Question 5 | |
Question 1 |
Question 20 | Pharmacology of sodium nitroprusside |
Question 18 | All about afterload |
Question 15 | |
Question 1 | Normal action potential vs. the action potential in a pacemaker cell |
Question 19 | |
Question 12 | |
Question 7 | |
Question 2 | Nitrate vasodilators: Pharmacology of GTN |
Question 18 | |
Question 16 | |
Question 14 | Beta-blockers: compare metoprolol and esmolol |
Question 6 | |
Question 2 |
Question 14 | |
Question 13 | Classification of shock, and circulatory responses to shock |
Question 8 | |
Question 4 | Functional anatomy of the kidney and regulation of renal blood flow |
Question 2 | Arterial line pressure transducer setup and waveform interpretation |
Question 18 | Factors affecting left ventricular function: afterload, contractility and preload |
Question 16 | Starling forces in the systemic circulation |
Question 6 | |
Question 2 |
Question 12 | The cardiac cycle: events during diastole |
Question 11 | |
Question 7 | Gastrointestinal blood supply: arteries and veins |
Question 2 | Adrenaline vs. milrinone |
Question 21 | |
Question 19 | Cardiac reflexes: vasovagal syncope |
Question 17 | |
Question 15 | Adrenaline: an ideal inotrope? |
Question 10 | |
Question 8 | Calcium channel blockers: pharmacology of nimodipine |
Question 23 | |
Question 20 | Pharmacology of vasoactive drugs: vasopressin and its analogues |
Question 19 | |
Question 15 |
Question 21 | Classification of antiarrhythmic agents and sotalol |
Question 19 | Starling forces in the pulmonary circulation |
Question 15 | |
Question 13 | |
Question 11 | |
Question 7 | Myocardial oxygen supply and demand: LV vs RV |
Question 2 | Nitrate vasodilators: GTN vs. nitroprusside |
Question 13 | Afterload: what would happen if it suddenly increased? |
Question 11 | Amiodarone: mainly the side effects |
Question 9 |
Question 23 | |
Question 15 | |
Question 3 | A comparison of hepatic and renal blood flow |
Question 19 | |
Question 12 | |
Question 11 | Nitrate vasodilators: Pharmacology of sodium nitroprusside |
Question 19 | |
Question 16 | Function of baroreceptors and clinical relevance of the baroreflex |
Question 13 | Amiodarone: pharmacology |
Question 10 | |
Question 1 |
Question 19 | Cardiac output: definition, determinants and thermodilution measurement |
Question 14 | |
Question 12 | |
Question 2 | Calcium channel blockers: pharmacology of verepamil |
Question 24 | |
Question 10 | Pharmacology of vasoactive agents: digoxin vs levosimendan |
Question 2 |
Question 22 | Pharmacology of vasoactive agents: Vasopressin and its analogues |
Question 19 | |
Question 18 | |
Question 10 | Pharmacology of antihypertensives: carvedilol and spironolactone |
Question 3 |
Question 23 | |
Question 18 | Adrenaline: an ideal inotrope? |
Question 9 | Classification of antiarrhythmic agents and Class I agent pharmacology |
Question 4 |
Question 24 | |
Question 17 | |
Question 11 | A comparison of hepatic and renal blood flow |
Question 9 | Physiological response to normal ageing: cardiovascular changes |
Question 8 | Pharmacology of vasoactive drugs: adrenaline vs. levosimendan |
Question 21 | Functional anatomy and physiology of renal medullary blood flow |
Question 17 | Calcium channel blockers: compare verapamil and nimodipine |
Question 16 | |
Question 14 | Pharmacology of vasoactive agents: dobutamine vs. milrinone |
Question 13 | Regulation of cardiac output via vascular function curves |
Question 9 | |
Question 6 | Humoral control of the circulation: the RAAS system |
Question 5 |
Question 21 | The cardiac cycle: events during diastole |
Question 18 | Starling forces and the mechanism of oedema formation |
Question 13 |
Relationship of the surface ECG to the events of the cardiac cycle |
Question 12 | Measurement of cardiac output by the indicator dilution technique |
Question 8 | Determinants of cardiac output: specifically, of the right ventricle |
Question 7 |
Question 24 | Classification of antihypertensive agents by mechanism |
Question 23 | The Cardiac Cycle and normal processes of cardiac electrical activity |
Question 22 | |
Question 17 |
Question 9(p.2) | |
Question 4(p.2) | |
Question 7 | |
Question 1 |
Question 6(p.2) | Humoral control of the circulation: specifically, angiotensin |
Question 12 | Pharmacology of vasoactive agents: noradrenaline |
Question 5 |
Question 11 | |
Question 7 | |
Question 1 | Relationship of surface ECG to the cardiac cycle |
Question 9(p.2) | The effects of ACE-inhibitors and ARBs on the management of CCF |
Question 8(p.2) | Nitrate vasodilators: GTN vs. nitroprusside |
Question 1(p.2) | |
Question 12 | |
Question 11 | |
Question 5 | Amiodarone: pharmacology |
Question 12(p.2) | |
Question 7(p.2) | Conduction system and counter-arrhythmic mechanisms |
Question 4(p.2) | |
Question 3(p.2) | Nitrate vasodilators: GTN vs. nitroprusside |
Question 12 | Classification of inotropes |
Question 10 | |
Question 5 |
Question 7(p.2) | |
Question 6(p.2) | |
Question 8 | Function of baroreceptors and clinical relevance of the baroreflex |
Question 1 |